Lichenoid drug eruption with proton pump inhibitors.
作者信息
Bong J L, Lucke T W, Douglas W S
机构信息
Department of Dermatology, Monklands Hospital, Airdrie ML6 OJS.
出版信息
BMJ. 2000 Jan 29;320(7230):283. doi: 10.1136/bmj.320.7230.283.
Abstract
摘要
相似文献
1
Lichenoid drug eruption with proton pump inhibitors.质子泵抑制剂所致苔藓样药疹
BMJ. 2000 Jan 29;320(7230):283. doi: 10.1136/bmj.320.7230.283.
2
Proton-pump inhibitors: three of a kind?质子泵抑制剂：同类的三种药物？
Lancet. 1997 Jun 7;349(9066):1637-8. doi: 10.1016/s0140-6736(05)62629-3.
3
[Cross reactivity among proton pump inhibitors: does it exits?].[质子泵抑制剂之间的交叉反应性：是否存在？]
Allergol Immunopathol (Madr). 2004 Mar-Apr;32(2):92-5. doi: 10.1016/s0301-0546(04)79235-6.
4
Nonallergic anaphylaxis to pantoprazole.对泮托拉唑的非过敏性过敏反应。
Allergy. 2002 Feb;57(2):184. doi: 10.1034/j.1398-9995.2002.1n3496.x.
5
A summary of Food and Drug Administration-reported adverse events and drug interactions occurring during therapy with omeprazole, lansoprazole and pantoprazole.美国食品药品监督管理局报告的在使用奥美拉唑、兰索拉唑和泮托拉唑治疗期间发生的不良事件及药物相互作用总结。
Aliment Pharmacol Ther. 2003 Apr;17(8):1015-9. doi: 10.1046/j.1365-2036.2003.01550.x.
6
Safety of proton pump inhibitors--an overview.质子泵抑制剂的安全性——概述
Aliment Pharmacol Ther. 1994;8 Suppl 1:65-70. doi: 10.1111/j.1365-2036.1994.tb00265.x.
7
Severe erythrodermic reactions to the proton pump inhibitors omeprazole and lansoprazole.对质子泵抑制剂奥美拉唑和兰索拉唑的严重红皮病反应。
Br J Dermatol. 1999 Jul;141(1):173-5. doi: 10.1046/j.1365-2133.1999.02953.x.
8
The rates of common adverse events reported during treatment with proton pump inhibitors used in general practice in England: cohort studies.英国全科医疗中使用质子泵抑制剂治疗期间报告的常见不良事件发生率：队列研究
Br J Clin Pharmacol. 2000 Oct;50(4):366-72. doi: 10.1046/j.1365-2125.2000.00262.x.
9
Apparent anaphylaxis associated with pantoprazole.与泮托拉唑相关的明显过敏反应。
Am J Health Syst Pharm. 2005 Jul 1;62(13):1388-9. doi: 10.2146/ajhp040375.
10
Reversible pheripheral edema in female patients taking proton pump inhibitors for peptic acid diseases.服用质子泵抑制剂治疗胃酸相关疾病的女性患者出现可逆性外周水肿。
Dig Dis Sci. 2001 May;46(5):993-6. doi: 10.1023/a:1010745624971.
引用本文的文献
1
Lichenoid Drug Eruption Secondary to Adalimumab: A Case Report.阿达木单抗继发苔藓样药疹：一例报告
Cureus. 2024 Jul 7;16(7):e64013. doi: 10.7759/cureus.64013. eCollection 2024 Jul.
2
Persistent cutaneous lesion in a child with tyrosinemia: Esomeprazole-induced lichenoid drug eruptions.一名患有酪氨酸血症儿童的持续性皮肤病变：埃索美拉唑诱发的苔藓样药疹。
Clin Case Rep. 2021 Aug 16;9(8):e04610. doi: 10.1002/ccr3.4610. eCollection 2021 Aug.
3
Proton pump inhibitors: use, misuse and concerns about long-term therapy.质子泵抑制剂：使用、误用及对长期治疗的担忧
Clin J Gastroenterol. 2011 Apr;4(2):53-9. doi: 10.1007/s12328-011-0208-y. Epub 2011 Feb 18.
4
[Delayed-type cutaneous drug reactions. Pathogenesis, clinical features and histology].[药物性迟发型皮肤反应。发病机制、临床特征及组织学]
Hautarzt. 2014 May;65(5):397-408. doi: 10.1007/s00105-013-2696-9.
5
[Anaphylaxis caused by omeprazole].[奥美拉唑引起的过敏反应]
Hautarzt. 2006 Nov;57(11):1016-8, 1020. doi: 10.1007/s00105-005-1076-5.
本文引用的文献
1
2
Safety of lansoprazole.兰索拉唑的安全性。
Aliment Pharmacol Ther. 1993;7 Suppl 1:56-60, discussion 61-6. doi: 10.1111/j.1365-2036.1993.tb00590.x.
Zotero 插件